112 related articles for article (PubMed ID: 20302518)
1. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
Kontos CK; Scorilas A
Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
[TBL] [Abstract][Full Text] [Related]
4. Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity.
Guo S; Skala W; Magdolen V; Brandstetter H; Goettig P
Biol Chem; 2014 Sep; 395(9):959-76. PubMed ID: 25153382
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.
Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC
J BUON; 2014; 19(1):53-9. PubMed ID: 24659643
[TBL] [Abstract][Full Text] [Related]
6. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.
Paniagua-Herranz L; Moreno I; Nieto-Jiménez C; Garcia-Lorenzo E; Díaz-Tejeiro C; Sanvicente A; Doger B; Pedregal M; Ramón J; Bartolomé J; Manzano A; Gyorffy B; Gutierrez-Uzquiza Á; Pérez Segura P; Calvo E; Moreno V; Ocana A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396898
[TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers.
Sananes A; Cohen I; Allon I; Ben-David O; Abu Shareb R; Yegodayev KM; Stepensky D; Elkabets M; Papo N
Mol Oncol; 2023 Nov; 17(11):2337-2355. PubMed ID: 37609678
[TBL] [Abstract][Full Text] [Related]
8. Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer.
Stuardo-Parada A; López-Muñoz R; Villarroel-Espindola F; Figueroa CD; Ehrenfeld P
Med Oncol; 2023 Jul; 40(8):224. PubMed ID: 37405520
[TBL] [Abstract][Full Text] [Related]
9. EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer.
Yu KJ; Ji DY; Hsieh ML; Chuang CK; Pang ST; Weng WH
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681793
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.
Chang JS; Kim N; Kim JY; Do SI; Cho Y; Kim HS; Kim YB
J Gynecol Oncol; 2020 Nov; 31(6):e78. PubMed ID: 33078588
[TBL] [Abstract][Full Text] [Related]
12. Multiplex enzyme activity imaging by MALDI-IMS of substrate library conversions.
Klein O; Haeckel A; Reimer U; Nebrich G; Schellenberger E
Sci Rep; 2020 Sep; 10(1):15522. PubMed ID: 32968143
[TBL] [Abstract][Full Text] [Related]
13. A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering.
Sananes A; Cohen I; Shahar A; Hockla A; De Vita E; Miller AK; Radisky ES; Papo N
J Biol Chem; 2018 Aug; 293(33):12663-12680. PubMed ID: 29934309
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer.
Du JP; Li L; Zheng J; Zhang D; Liu W; Zheng WH; Li XS; Yao RC; Wang F; Liu S; Tan X
Oncotarget; 2018 Feb; 9(16):12894-12906. PubMed ID: 29560118
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.
Seliga A; Lee MH; Fernandes NC; Zuluaga-Ramirez V; Didukh M; Persidsky Y; Potula R; Gallucci S; Sriram U
Front Immunol; 2018; 9():156. PubMed ID: 29456540
[TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein 10 predicts the incurability of gastric cancer.
Shimura T; Ebi M; Yamada T; Yamada T; Katano T; Nojiri Y; Iwasaki H; Nomura S; Hayashi N; Mori Y; Kataoka H; Moses MA; Joh T
Oncotarget; 2017 Apr; 8(17):29247-29257. PubMed ID: 28418926
[TBL] [Abstract][Full Text] [Related]
17. Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
Tokas T; Avgeris M; Alamanis C; Scorilas A; Stravodimos KG; Constantinides CA
J Cancer Res Clin Oncol; 2017 Mar; 143(3):521-532. PubMed ID: 27858162
[TBL] [Abstract][Full Text] [Related]
18. SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.
Zheng LS; Yang JP; Cao Y; Peng LX; Sun R; Xie P; Wang MY; Meng DF; Luo DH; Zou X; Chen MY; Mai HQ; Guo L; Guo X; Shao JY; Huang BJ; Zhang W; Qian CN
Cancer Res; 2017 Jan; 77(2):579-589. PubMed ID: 27671677
[TBL] [Abstract][Full Text] [Related]
19. A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.
Lee SW; Hosokawa K; Kim S; Jeong OC; Lilja H; Laurell T; Maeda M
Sensors (Basel); 2015 May; 15(5):11972-87. PubMed ID: 26007739
[TBL] [Abstract][Full Text] [Related]
20. Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.
Zhang CY; Zhu Y; Rui WB; Dai J; Shen ZJ
Asian J Androl; 2015; 17(1):106-10. PubMed ID: 25219913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
